Synopsis
Synopsis
0
KDMF
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 441.4 g/mol |
---|---|
Molecular Formula | C19H19N7O6 |
XLogP3 | -1.1 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 9 |
Exact Mass | 441.13968135 g/mol |
Monoisotopic Mass | 441.13968135 g/mol |
Topological Polar Surface Area | 209 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 767 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Folic acid |
PubMed Health | Folic Acid |
Drug Classes | Nutriceutical, Nutritive Agent |
Drug Label | Folic acid, N-[p-[[(2-amino-4-hydroxy-6-pteridiny)methyl]amino]benzoyl]-L-glutamic acid, is a B complex vitamin containing a pteridine moiety linked by a methylene bridge to para-aminobenzoic acid, which is joined by a peptide linkage to glutamic aci... |
Active Ingredient | Folic acid |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 1 mg; 1mg; 5mg/ml |
Market Status | Prescription |
Company | Bicon Pharm; Excellium; Jubilant Cadista; Cadila Pharms; Invagen Pharms; Hikma Pharms; Watson Labs; Amneal Pharm; Fresenius Kabi Usa; Vintage; Contract Pharmacal |
2 of 2 | |
---|---|
Drug Name | Folic acid |
PubMed Health | Folic Acid |
Drug Classes | Nutriceutical, Nutritive Agent |
Drug Label | Folic acid, N-[p-[[(2-amino-4-hydroxy-6-pteridiny)methyl]amino]benzoyl]-L-glutamic acid, is a B complex vitamin containing a pteridine moiety linked by a methylene bridge to para-aminobenzoic acid, which is joined by a peptide linkage to glutamic aci... |
Active Ingredient | Folic acid |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 1 mg; 1mg; 5mg/ml |
Market Status | Prescription |
Company | Bicon Pharm; Excellium; Jubilant Cadista; Cadila Pharms; Invagen Pharms; Hikma Pharms; Watson Labs; Amneal Pharm; Fresenius Kabi Usa; Vintage; Contract Pharmacal |
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
83
PharmaCompass offers a list of Folic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Folic Acid manufacturer or Folic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Folic Acid manufacturer or Folic Acid supplier.
PharmaCompass also assists you with knowing the Folic Acid API Price utilized in the formulation of products. Folic Acid API Price is not always fixed or binding as the Folic Acid Price is obtained through a variety of data sources. The Folic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Acidum folicum [INN-Latin] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acidum folicum [INN-Latin], including repackagers and relabelers. The FDA regulates Acidum folicum [INN-Latin] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acidum folicum [INN-Latin] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acidum folicum [INN-Latin] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acidum folicum [INN-Latin] supplier is an individual or a company that provides Acidum folicum [INN-Latin] active pharmaceutical ingredient (API) or Acidum folicum [INN-Latin] finished formulations upon request. The Acidum folicum [INN-Latin] suppliers may include Acidum folicum [INN-Latin] API manufacturers, exporters, distributors and traders.
click here to find a list of Acidum folicum [INN-Latin] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acidum folicum [INN-Latin] DMF (Drug Master File) is a document detailing the whole manufacturing process of Acidum folicum [INN-Latin] active pharmaceutical ingredient (API) in detail. Different forms of Acidum folicum [INN-Latin] DMFs exist exist since differing nations have different regulations, such as Acidum folicum [INN-Latin] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acidum folicum [INN-Latin] DMF submitted to regulatory agencies in the US is known as a USDMF. Acidum folicum [INN-Latin] USDMF includes data on Acidum folicum [INN-Latin]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acidum folicum [INN-Latin] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acidum folicum [INN-Latin] suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Acidum folicum [INN-Latin] Drug Master File in Japan (Acidum folicum [INN-Latin] JDMF) empowers Acidum folicum [INN-Latin] API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Acidum folicum [INN-Latin] JDMF during the approval evaluation for pharmaceutical products. At the time of Acidum folicum [INN-Latin] JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Acidum folicum [INN-Latin] suppliers with JDMF on PharmaCompass.
A Acidum folicum [INN-Latin] CEP of the European Pharmacopoeia monograph is often referred to as a Acidum folicum [INN-Latin] Certificate of Suitability (COS). The purpose of a Acidum folicum [INN-Latin] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Acidum folicum [INN-Latin] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Acidum folicum [INN-Latin] to their clients by showing that a Acidum folicum [INN-Latin] CEP has been issued for it. The manufacturer submits a Acidum folicum [INN-Latin] CEP (COS) as part of the market authorization procedure, and it takes on the role of a Acidum folicum [INN-Latin] CEP holder for the record. Additionally, the data presented in the Acidum folicum [INN-Latin] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Acidum folicum [INN-Latin] DMF.
A Acidum folicum [INN-Latin] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Acidum folicum [INN-Latin] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Acidum folicum [INN-Latin] suppliers with CEP (COS) on PharmaCompass.
A Acidum folicum [INN-Latin] written confirmation (Acidum folicum [INN-Latin] WC) is an official document issued by a regulatory agency to a Acidum folicum [INN-Latin] manufacturer, verifying that the manufacturing facility of a Acidum folicum [INN-Latin] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acidum folicum [INN-Latin] APIs or Acidum folicum [INN-Latin] finished pharmaceutical products to another nation, regulatory agencies frequently require a Acidum folicum [INN-Latin] WC (written confirmation) as part of the regulatory process.
click here to find a list of Acidum folicum [INN-Latin] suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acidum folicum [INN-Latin] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acidum folicum [INN-Latin] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acidum folicum [INN-Latin] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acidum folicum [INN-Latin] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acidum folicum [INN-Latin] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acidum folicum [INN-Latin] suppliers with NDC on PharmaCompass.
Acidum folicum [INN-Latin] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acidum folicum [INN-Latin] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acidum folicum [INN-Latin] GMP manufacturer or Acidum folicum [INN-Latin] GMP API supplier for your needs.
A Acidum folicum [INN-Latin] CoA (Certificate of Analysis) is a formal document that attests to Acidum folicum [INN-Latin]'s compliance with Acidum folicum [INN-Latin] specifications and serves as a tool for batch-level quality control.
Acidum folicum [INN-Latin] CoA mostly includes findings from lab analyses of a specific batch. For each Acidum folicum [INN-Latin] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acidum folicum [INN-Latin] may be tested according to a variety of international standards, such as European Pharmacopoeia (Acidum folicum [INN-Latin] EP), Acidum folicum [INN-Latin] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acidum folicum [INN-Latin] USP).